Skip to Content

Roche turns around diabetes sales

Roche turns around diabetes sales

NEW YORK - Roche Diagnostics saw North American diabetes sales of $112 million for the first quarter of 2014, a 13% increase over the same period a year ago, according to news reports. The company's sales of glucose monitors decreased 16% in 2013, mainly due to Medicare's national mail-order program for diabetes supplies, which resulted in a reimbursement cut of, on average, 72%. The program kicked of July 1, 2013. Roche tried unsuccessfully to sell its diabetes division last year.

Comments

To comment on this post, please log in to your account or set up an account now.